J Leukoc Biol. 2026 Apr 2;118(4):qiag027. doi: 10.1093/jleuko/qiag027.
ABSTRACT
The basis for differential susceptibility to Leishmania donovani infection observed in individuals remains poorly understood. Here we address this important open question comparing bone marrow-derived macrophages (BMDMs) from susceptible hamsters (hamBMDMs) and resistant mice (mBMDMs) to identify intrinsic cellular features that may contribute to host-specific outcomes. We first optimized and validated an experimental protocol for generating hamBMDMs, which closely resemble classical mBMDMs in terms of morphology, marker gene expression, and phagocytic activity. Comparative transcriptomic analysis uncovered rodent-specific intrinsic differences in the expression of metabolic and immune-related pathways known to influence susceptibility to intracellular Leishmania infection. Notably, hamBMDMs were characterized by the expression of Lyve1, a marker of tissue-resident macrophages involved in extracellular matrix homeostasis, which may contribute to their distinct functional profile. In vitro infection assays confirmed the microbicidal capacity of hamBMDMs and also revealed their increased permissiveness to Leishmania proliferation. In conclusion, the combined use of murine and hamster macrophage systems provides a powerful platform to dissect the molecular mechanisms underlying L. donovani survival and host resistance. Our improved protocol allows for the generation of large quantities of functionally validated hamster macrophages, enabling systems-level investigations in this important rodent model that more accurately reflects human infection dynamics than mice. This addresses a major bottleneck in experimental infections with L. donovani, but also other clinically relevant pathogens, such as Mycobacterium spp. and SARS-CoV-2, for which hamsters have been used to model human infection.
PMID:41934282 | DOI:10.1093/jleuko/qiag027